References:
Abdul-Ridha A, Lopez L, Keov P, Thal DM, Mistry SN, PM (2014) Molecular
Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine
Receptor J. Biol. Chem. Chem. 289: 6068-6079.
Allen JA, Yost JM, Setola V, Chen X, Sassano MF, Chen M, Peterson S,
Yadav PN, Huang XP, Feng B, et al. (2011) Discovery of β-arrestin-biased
dopamine D2 ligands for probing signal transduction pathways essential
for antipsychotic efficacy. Proc Natl Acad Sci USA 108: 18488-18493.
Arrowsmith J (2011) Trial watch: phase II failures: 2008–2010. Nat Rev
Drug Discov 10:328–329
Audet N, Galés C, Archer-Lahlou E, Vallières M, Schiller PW, Bouvier M,
and Pineyro G (2008) Bioluminescence resonance energy transfer assays
reveal ligand-specific conformational changes within preformed signaling
complexes containing delta-opioid receptors and heterotrimeric G
proteins. J Biol Chem 283: 15078–15088
.Aurelio L, Baltos J-A, Ford L, Nguyen ATN, Jörg M, Devine SM, Valant C,
White PJ, Christopoulos A, May LT, et al. (2018) A structure-activity
relationship study of bitopic N6-substituted adenosine derivatives as
biased adenosine A1 receptor agonists. J Med Chem 61:2087–2103
Baltos JA, Vecchio EA, Harris MA, Qin CX, Ritchie RH, Christopoulos A,
White PJ, and May LT (2017) Capadenoson, a clinically trialed partial
adenosine A1 receptor agonist, can stimulate adenosine A2B receptor
biased agonism. Biochem Pharmacol 135:79–89
Baker JG, Hall IP, and Hill SJ (2003) Agonist and inverse agonist
actions of beta blockers at the human beta 2-adrenoceptor provide
evidence for agonist-directed signaling. Mol Pharmacol 64:1357–1369.
Black JW and Leff P (1983) Operational models of pharmacological
agonism. Proc R Soc Lond B Biol Sci 220:141–162
Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ,
Dykstra LA, and Caron MG (2003) Enhanced rewarding properties of
morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J
Neurosci 23:10265–10273.
Bunnage ME, Piatnitski Chekler EL, Jones LH. (2013) Target validation
using chemical probes Nature Chem Biol 9:195–199.
Cahill, T. J. III Thomsen ARB, Tarrasch JT, Plouffee B, Nguyen AH, Yangg
F, et al (2017) Distinct conformations of GPCR–β-arrestin complexes
mediate desensitization, signaling, and endocytosis. Proc. Natl. Acad.
Sci. USA 114, 2562–2567(2017).
Cai B, El Daibani A, Bai Y, Che T, Krusemark CJ.(2023) Direct Selection
of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells JACS
3(4):1076-1088. doi: 10.1021/jacsau.2c00674
Cao Y, van der Velden WJC, Namkung Y, Nivedha AK, Cho A, Sedki D,
Holleran B, et al (2023) Unraveling allostery within the angiotensin II
type 1 receptor for Gαq and β-arrestin coupling. Sci Signal. 16(797):
Che T, Dwivedi-Agnihotri H, Shukla AK, Roth BL. (2021) Biased ligands at
opioid receptors: Current status and future directions Sci Signal. ;
14(677): doi:10.1126/scisignal.aav0320
Chen Q, Tesmer JJG. (2022) G protein-coupled receptor interactions with
arrestins and GCR kinases: The unresolved issue of signal bias. J Biol.
Chem. 298:102279.
Chen K, Zhang C, Lin S, Yan X, Cai H, Yi C. et al (2023) Tail engagement
of arrestin at the glucagon receptor. Nature
https://www.nature.com/articles/s41586-023-06420
Cho HP, Engers DW,Venable DF,Niswender CM, Lindsley CW, et al (2014) A
Novel Class of Succinimide-Derived Negative Allosteric Modulators of
Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a
Disconnect in Activity between the Rat and Human Receptors ACS Chem.
Neurosci. 5:597−610
Christmanson L, Westermark P, and Betsholtz C (1994) Islet amyloid
polypeptide stimulates cyclic AMP accumulation via the porcine
calcitonin receptor. Biochem Biophys Res Commun 205:1226–1235.
Conibear AE, Kelly E. (2019) A Biased View of µ-Opioid Receptors? Mol
Pharmacol 96: 542-549
Conibear AE, Asghar J, Hill R, Henderson G, Borbely E, Tekus V, Helyes
Z, Palandri J, Bailey C, Starke I, von Mentzer B, et al. (2020) A novel
G protein-biased agonist at the δ opioid receptor with analgesic
efficacy in models of chronic pain. J Pharmacol Exp Ther.; 372:224–236.
[PubMed: 31594792
Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, et al
(2014) Lessons learned from the fate of AstraZeneca’s drug pipeline: a
five-dimensional framework Nature Rev Drug Disc 13:419–431.
Darbalaei S, Yuliantie E, Dai A, Chang R, Zhao P, Yang D, et al (2020)
Evaluation of biased agonism mediated by dual agonists of the GLP-1 and
glucagon receptors Biochem Pharmacol 180:114150.
Devost D, Sleno R, Pétrin D, Zhang A, Shinjo Y, Okde R, Aoki J, Inoue A,
and Hébert TE (2017) Conformational profiling of the AT1 angiotensin II
receptor reflects biased agonism, G protein coupling, and cellular
context. J Biol Chem 292:5443–5456
Drube J, Haider RS, Matthees E, Reichel M, Zeiner J, Fritzwanker S, et
al ( 2022) GPCR kinase knockout cells reveal the impact of individual
GRKs on arrestin binding and GPCR regulation Nature Commun 13:540
Duan J, Liu H, Zhao F, Yuan Q, Ji Y, Cai X, He X,et al (2023) GPCR
activation and GRK2 assembly by a biased intracellular agonist. Nature.
doi: 10.1038
Eason MG, Kurose H, Holt BD, Raymond JR, and Liggett SB (1992)
Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins
with opposing effects. Subtype-selective coupling of alpha 2C10, alpha
2C4, and alpha 2C2 adrenergic receptors to Gi and Gs. J Biol Chem
267:15795–15801.
Eiger DS, Boldizsar N, Honeycutt CC, Gardner J, Kirchner S, Hicks C, et
al (2022) Location bias contributes to functionally selective responses
of biased CXCR3 agonists. Nature Commun 13: 5846.
El Daibani AE, Paggi JM, Kim K, Laloudakis YD, Popov P, Bernhard SM, et
al (2023) Molecular mechanism of biased signaling at the kappa opioid
receptor Nature Commun 14:1338
Erickson CE, Gul R, Blessing CP, Nguyen J, Liu T, Pulakat L, Bastepe M,
Jackson EK, and Andresen BT (2013) The β-blocker nebivolol is a
GRK/β-arrestin biased agonist. PLoS One 8:e71980.
Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, Lin FT, Manen
D, and Bouxsein ML (2005) Bone response to intermittent parathyroid
hormone is altered in mice null for β-arrestin2. Endocrinology
146:1854–1862
Fletcher MM, Halls ML, Zhao P, Clydesdale L, Christopoulos A, Sexton,
Wootten D. (2018) Glucagon-like peptide-1 receptor internalization
controls spatiotemporal signalling mediated by biased agonists. Biochem
Pharmacol. 156:406-419.
Gentry, P. R., Kokubo, M., Bridges, T. M., Kett, N. R., Harp, J. M.,
Cho, H. P., et al. (2013). Discovery of the first M5-selective and CNS
penetrant negative allosteric modulator (NAM) of a muscarinic
acetylcholine receptor: (S)-9b-(4- chlorophenyl)-1-(3, 4
difluorobenzoyl)-2, 3-dihydro-1H-imidazo[2, 1-a] isoindol-5(9bH)-one
(ML375). J. Med. Chem. 56, 9351–9355
Ghanouni P, Gryczynski Z, Steenhuis JJ, Lee TW, Farrens DL, Lakowicz JR,
and Kobilka BK (2001) Functionally different agonists induce distinct
conformations in the G protein coupling domain of the beta 2 adrenergic
receptor. J Biol Chem 276:24433–24436.
Gregory KJ, Hall NE, Tobin AB, Sexton PM, Christopoulos A. (2010)
Identification of Orthosteric and Allosteric Site Mutations in M2
Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective
Signaling Bias J Biol Chem 285:7459-7474.
Haider RS, Reichel M, Matthees ESF, Hoffmann C. (2023) Conformational
flexibility of β-arrestins-How these scaffolding proteins guide and
transform the functionality of GPCRs. BioEssays 45: 2300053.
Hellyer SD, Sengmany K, Keller AN, Christopoulos A, Leach K, Gregory KJ.
(2020) Probe dependence and biased potentiation of metabotropic
glutamate receptor 5 is mediated by differential ligand interactions in
the common allosteric binding site. Biochem Pharmacol. 2020
Jul;177:114013.
Jarpe MB, Knall C, Mitchell FM, Buhl AM, Duzic E, and Johnson GL (1998)
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist
toward neuropeptide and chemokine receptors. J Biol Chem 273:3097–3104.
Jiang Y, Yeasmin M, Gondin AB, Christopoulos A, Valant C, Burger WAC, et
al, (2022) Importance of receptor expression in the classification of
novel ligands at the M2 muscarinic acetylcholine receptor. Br. J
Pharmacol doi: 10.1111/bph.16021.
Johnson TA, Milan-Lobo L, Che T, Ferwerda M, Lambu E, McIntosh NL, Li F,
He L, Lorig-Roach N, Crews P, et al. (2017) Identification of the first
marine-derived opioid receptor “balanced” agonist with a signaling
profile that resembles the endorphins. ACS Chem Neurosci 8:473–485.
Jones B. (2021) The therapeutic potential of GLP-1 receptor biased
agonism Br J Pharmacol. 2022;179:492–510.
Jozwiak K, Toll L, Jimenez L, Woo AY-H, Xiao R-P, and Wainer IW (2010)
The effect of stereochemistry on the thermodynamic characteristics of
the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.
Biochem Pharmacol 79:1610–1615
Kayser C, Melkes B, Derieux C, Bock A. (2023) Spatiotemporal GPCR
signaling illuminated by genetically encoded fluorescent biosensors.
Curr Opin Pharmacol. 71:102384.
Kenakin TP. (1984) The relative contribution of affinity and efficacy to
agonist activity: organ selectivity of noradrenaline and oxymetazoline
with reference to the classification of drug receptors. Br J Pharmacol.
81(1):131-41.
Kenakin T (1995) Agonist-receptor efficacy. II. Agonist trafficking of
receptor signals. Trends Pharmacol Sci 16:232–238.
Kenakin TP (2003) Ligand-selective receptor conformations revisited: the
promise and the problem. Trends Pharmacol Sci 24: 346-354.
Kenakin T (2005) New concepts in drug discovery: collateral efficacy and
permissive antagonism. Nat Rev Drug Discov 4:919–927.
Kenakin T (2017) A scale of agonism and allosteric modulation for
assessment of selectivity, bias, and receptor mutation Mol Pharmacol
92:414–424.
Kenakin T. (2019) Biased Receptor Signaling in Drug Discovery Pharmacol
Rev. 7:267-315
Kenakin, TP (2021) Biased agonism as allosteric probe dependence. Cell
Signal. 79: 109844.
Kenakin TP and Morgan PH (1989) Theoretical effects of single and
multiple transducer receptor coupling proteins on estimates of the
relative potency of agonists. Mol Pharmacol 35:214–222.
Kenakin T, Onaran O. (2002) The ligand paradox between affinity and
efficacy: can you be there and not make a difference? Trends Pharmacol
Sci. 23:275-80. doi: 10.1016/s0165-6147(02)02036-9
Kenakin T, Watson C, Muniz-Medina V, Christopoulos A, and Novick S
(2012) A simple method for quantifying functional selectivity and
agonist bias. ACS ChemNeurosci 3:193–203.
Kim IM, Tilley DG, Chen J, Salazar NC, Whalen EJ, Violin JD, and Rockman
HA (2008) β-blockers alprenolol and carvedilol stimulate
β-arrestin-mediated EGFR transactivation. Proc Natl Acad Sci USA
105:14555–14560.
Klein Herenbrink C, Sykes DA, Donthamsetti P, Canals M, Coudrat T,
Shonberg J, Scammells PJ, Capuano B, Sexton PM, Charlton SJ, et al.
(2016) The role of kinetic context in apparent biased agonism at GPCRs.
Nat Commun 7:10842
Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, and Struthers RS
(2004) Differential desensitization, receptor phosphorylation,
beta-arrestin recruitment, and ERK1/2 activation by the two endogenous
ligands for the CC chemokine receptor
Kolb P, Kenakin T, Alexander SPH, Bermudez M, Bohn LM, Breinholt CS, et
al (2022) Community guidelines for GPCR ligand bias: IUPHAR review Br J
Pharmacol.179:3651-3674.
Krumm BE, DiBerto JF, Olsen RHJ, Kang HJ, Slocum ST, Zhang S, et al
(2023) Neurotensin Receptor Allosterism Revealed in Complex with a
Biased Allosteric Modulator Biochem. 62: 1233-1248
Kudlacek O, Waldhoer M, Kassack MU, Nickel P, Salmi JI, Freissmuth M,
and Nanoff C (2002) Biased inhibition by a suramin analogue of
A1-adenosine receptor/G protein coupling in fused receptor/G protein
tandems: the A1-adenosine receptor is predominantly coupled to Go-alpha
in human brain. Naunyn Schmiedebergs Arch Pharmacol 365:8–16.
Lambert D, Calo G. (2020) Approval of oliceridine (TRV130) for
intravenous use in moderate to severe pain in adults Br. J Anaesthes.
10.106/j.bja.2020.09.021
Laschet C, Dupuis N, Hanson J, (2019) A dynamic and screening-compatible
nanoluciferase-based complementation assay enables profiling of
individual GPCR–G protein interactions. J Biol. Chem. 294: 4079-4090
Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM,
Sibley DR, and Mailman RB (1999) Interactions of the novel antipsychotic
aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes
Neuropsychopharmacology 20:612–627
Leandera M, Tuanb Y, Megera A, Cuib Q, Raman S. (2020) Functional
plasticity and evolutionary adaptation of allosteric regulation. Proc
Natl Acad Sci 117: 25445-25454
Le Rouzic V, Narayan A, Hunkle A, Marrone GF, Lu Z, Majumdar S, Xu J,
Pan YX, and Pasternak GW (2019) Pharmacological characterization of
levorphanol, a G-protein biased opioid analgesic. Anesth Analg
128:365–373
Li A, Samuel Liu S, Huang R, Ahn S, Lefkowitz RJ, (2023) Loss of biased
signaling at a G protein-coupled receptor in overexpressed systems
(2023) PLOS ONE |
https://doi.org/10.1371
/journal.pone.0283477
Liu H, Ma H, Zeng X, Wu C, Acharya S, Sudan SK, et al (2023)
Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling
Pathway of Dopamine D2 Receptors to Activate ERK Kinases. Int J Mol Sci.
24(12):10031.
Liu H, Acharya S, Sudan SK, Hu L, Wu C, Cao Y, et al (2023) Comparative
study of the molecular mechanisms underlying the G protein and
β-arrestin-dependent pathways that lead to ERKs activation upon
stimulation by Dopamine D2 receptor. FEBS J.. doi: 10.1111/febs.16921.
Liu JJ, Horst R, Katritch V, Stevens RC, Wuthrich K et al (2012) Biased
signaling pathways in α2-adrenergic receptor characterized by19F-NMR. Science 335: 1106-1110
Luscombe VB, Baena-Lopez L, Bataille CJR, Russell AJ, Greaves DR (2023)
Kinetic insights into agonist-dependent signalling bias at the
pro-inflammatory G-protein coupled receptor GPR84 Eur Pharmacol
0014-2999
Luttrell LM, Maudsley S, Gesty-Palmer D. (2018) Translating in vitro
ligand bias to in vivo efficacy. Cell Signal. 41: 46-55.
Lutz JA, Sulima A, Gutman ES, Bow EW, Luo D, Kaska S, et al (2023)
Discovery of a Potent Highly Biased MOR Partial Agonist among
Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans. Molecules. 28:4795.
Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N,
Marsh M, Stangassinger M, Borlat F, et al. (1998) Aminooxypentane-RANTES
induces CCR5 internalization but inhibits recycling: a novel inhibitory
mechanism of HIV infectivity. J Exp Med 187:1215–1224.
Manning DR (2002) Measures of efficacy using G proteins as endpoints:
differential engagement of G proteins through single receptors. Mol
Pharmacol 62:451 452.
Mao L, Wei W, Chen J. (2023) Biased regulation of glucocorticoid
receptors signaling. Biomed Pharmacother. 165:115145.
Matthees ES, Haider RS, Hoffmann C, Drube (2021) Differential Regulation
of GPCRs—Are GRK Expression Levels the Key? Front. Cell Develop. Biol.
9: 687489.
Maudsley J, S, Martin B, Janssens MB, J, Etienne H, Jushaj A, van
Gastela J, et al (2016) Informatic Deconvolution of Biased GPCR
Signaling Mechanisms from in vivo Pharmacological Experimentation
Methods. 1; 92: 51–63.
McDonald JK, van der Westhuizen E, Pham, V, Thompson G, Felder CC, Paul
SM, (2022) Biased profile of xanomeline at the recombinant human m4
muscarinic acetylcholine receptor. ACS Chem Neurosci. 13:1206-1218
Mende F, Hundahl C, Plouffe B, Skova LJ, Sivertsena B, Madsena AN, et al
(2018) Translating biased signaling in the ghrelin receptor system into
differential in vivo functions Proc Natl Acad Sci USA 115: E10255-E10264
Morgan P, Van Der Graaf PH, Arrowsmith J, Feltner DE, Drummond KS,
Wegner CD, Street SDA. (2012) Can the flow of medicines be improved?
Fundamental pharmacokinetic and pharmacological principles toward
improving Phase II survival Drug Disc Today 17:419-424.
Morgan P, Brown DG, Lennard S, Anderton MJ, Barrett CJ, Eriksson U, et
al (2018) Impact of a five-dimensional framework on R&D productivity at
AstraZeneca Nature Rev Drug Disc 17: 167–181
Myslivecek J (2022) Multitargeting nature of muscarinic orthosteric
agonists and antagonists. Front. Physiol. 13
https://doi.org/10.3389
Namkung Y, Legouill C, Kumar S, Cao Y, Teixeira A, Lukasheva V, et al
(2018) Functional selectivity profiling of the angiotensin II type 1
receptor using pathway-wide BRET signaling sensors Sci Signal 11: 559.
Olsen RHJ, DiBerto JF, English JG, et al. (2020) TRUPATH, an open-source
biosensor platform for interrogating the GPCR transducerome. Nat Chem
Biol. 16:841-849
Onaran HO, Ambrosio C, Ugur Ö, Madaras Koncz E, Grò MC, Vezzi V,
Rajagopal S, Costa T (2017) Systematic errors in detecting biased
agonism: analysis of current methods and development of a new model-free
approach. Sci Rep 7:44247
Park JC, Luebbers A, Dao M, Semeano A, Nguyen AM, Papakonstantinou MP,
et al (2023) Fine-tuning GPCR-mediated neuromodulation by biasing
signaling through different G protein subunits.Mol Cell.
83(14):2540-2558.e12
Pang PS, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz P, et al
(2017) Biased ligand of the angiotensin II type 1 receptor in patients
with acute heart failure; a randomized, double-blind,
placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF). Eur.
Heart J. 38: 2364-2373.
Pedersen MF, Wróbel TM, Märcher-Rørsted E, Pedersen DS, Møller TC,
Gabriele F, et al (2020) Biased agonism of clinically approved μ-opioid
receptor agonists and TRV130 is not controlled by binding and signaling
kinetics Neuropharma 166: 107718
Peters MF and Scott CW (2009) Evaluating cellular impedance assays for
detection of GPCR pleiotropic signaling and functional selectivity. J
Biomol Screen 14:246–255
Pottie E, Poulie CBM, Simon IA, Harpsøe K, D’Andrea L, Komarov I, et al,
(2023) Structure−Activity Assessment and In-Depth Analysis of Biased
Agonism in a Set of Phenylalkylamine 5‑HT2A Receptor Agonists ACS Chem.
Neurosci. 14: 2727−2742
Raehal KM, Walker JK, and Bohn LM (2005) Morphine side effects in
β-arrestin 2 knockout mice. J Pharmacol Exp Ther 314:1195–1201
Raehal KM and Bohn LM (2011) The role of beta-arrestin2 in the severity
of antinociceptive tolerance and physical dependence induced by
different opioid pain therapeutics Neuropharmacology 60:58–65.
Rajagopal S, Ahn S, Rominger DH, Gowen-MacDonald W, Lam CM, Dewire SM,
(2011) Quantifying ligand bias at seven-transmembrane receptors Mol
Pharmacol 80:367-77.
Randakova A, Jakubic J (2021) Functionally selective and biased agonists
for muscarinic receptor. Pharmacol Res. 169:105641
Roth BL and Chuang DM (1987) Multiple mechanisms of serotonergic signal
transduction. Life Sci 41:1051–1064.
Sarma P, Carino CMC, Seetharama D, Pandey S, Dwivedi-Agnihotri H, Rui X,
et al (2023) Molecular insights into intrinsic transducer-coupling bias
in the CXCR4-CXCR7 system Nature Communications 14, Article number: 4808
Sengmany K, Hellyer SD, Christopoulos A, Lapinsky DJ, Leach K, Gregory
KJ. (2020) Differential contribution of metabotropic glutamate receptor
5 common allosteric binding site residues to biased allosteric agonism
Biochem Pharmacol. 2020 Jul;177:11401
Shukla AK, Westfield GH, Xiao K, Reis RI, Huang L-Y, Tripathi-Shukla P,
et al (2014) Visualization of arrestin recruitment by a
G-protein-coupled receptor. Nature 512, 218–222 (2014).
Singleton S, Baptista-Hon DT, Edelstein E, McCaughey KS, Camplisson E,
Hales TG (2021) TRV130 partial agonism and capacity to induce
anti-nociceptive tolerance revealed through reducing available µ-opioid
receptor number. Br J Pharmacol 178: 1855-1868
Skerrit JH, MacDonald RL (1984) Benzodiazepine receptor ligand actions
on responses, Benzodiazepines, CL218872, zoplicone. Eur. J Pharmacol.
101: 127.
Soave M, Kellam B, Woolard J, Briddon SJ, Hill SJ. (2020) NanoBit
Complementation to Monitor Agonist-Induced Adenosine A1 Receptor
Internalization SLAS Disc. 25: 186-194
Sonoda N, Imamura T, Yoshizaki T, Babendure JL, Lu JC, and Olefsky JM
(2008) Beta-arrestin-1 mediates glucagon-like peptide-1 signaling to
insulin secretion in cultured pancreatic beta cells. Proc Natl Acad Sci
USA 105:6614–6619.
Sugihara S, Burnett JC. (2017) BAST-AHF: Insights into biased AT1
ligands and heart failure: Beginning of the end or end of the beginning?
Eur. Heart J. 38:2374-2376.
Suomivuori CM, Latorraca NR, Wingler LM, Eismann S, King MC, Kleinhenz
ALW, et al (2020) Molecular mechanism of biased signaling in a
prototypical G protein-coupled receptor. Science. 2020 Feb
21;367(6480):881-887
Tschammer N, Bollinger S, Kenakin T, Gmeiner P (2011) Histidine 6.55 Is
a Major Determinant of Ligand-Biased Signaling in Dopamine D Receptor
Mol Pharmacol 79:575–585
Urs NM and Caron MG (2014) The physiological relevance of functional
selectivity in dopamine signalling. Int J Obes Suppl 4 (Suppl 1):S5–S8
van der Westhuizen ET, Choy KHC, Valant C, McKenzie-Nickson S, Bradley
SJ, Tobin AB, et al (2021) Fine Tuning Muscarinic Acetylcholine Receptor
Signaling Through Allostery and Bias. Front Pharmacol. 11:606656.
Violin JD, Lefkowitz RJ. (2007) β-Arrestin-biased ligands at
seven-transmembrane receptors Trends Pharmacol Sci 28: 416-422.
Violin JD, Dewire SM, Barnes WG, and Lefkowitz RJ (2006) G
protein-coupled receptor kinase and beta-arrestin-mediated
desensitization of the angiotensin II type1A receptor elucidated by
diacylglycerol dynamics. J Biol Chem 281:36411–36419.
Violin JD, DeWire SM, Yamashita D, Rominger DH, Nguyen L, Schiller K,
Whalen EJ, Gowen M, and Lark MW (2010) Selectively engaging β-arrestins
at the angiotensin II type 1 receptor reduces blood pressure and
increases cardiac performance. Pharmacol Exp Ther 335:572–579.
Violin JD, Crombie AL, Soergel DG, and Lark MW (2014) Biased ligands at
G-protein-coupled receptors: promise and progress. Trends Pharmacol Sci
35: 308–316.
Viscusi ER, Skobieranda F, Soergel DG, Cook E, Burt DA, Singla N.
APOLLO-1: (2019) A randomized placebo and active-controlled phase III
study investigating oliceridine (TRV130), a G protein biased ligand at
the μ-opioid receptor, for management of moderate-to-severe acute pain
following bunionectomy. J Pain Res. 2019; 12:927–943. [PubMed:
30881102]
Vuckovic Z, Wang J, Pham V, Mobbs JI, Belousoff MJ, Bhattarai A, et al
(2023) Pharmacological hallmarks of allostery at the M4 muscarinic
receptor elucidated through structure and dynamics eLife 2023;12:e83477
Wang S, Peng L, Kim KM. (2023)
Biased Dopamine D2 Receptors Exhibit Distinct Intracellular Trafficking
Properties and ERK Activation in Different Subcellular Domains. Biomol
Ther doi: 10.4062
Watson C, Chen G, Irving P, Way J, Chen WJ, and Kenakin T (2000) The use
of stimulus-biased assay systems to detect agonist-specific receptor
active states: implications for the trafficking of receptor stimulus by
agonists. Mol Pharmacol 58: 1230–1238
Whistler JL and von Zastrow M (1999) Dissociation of functional roles of
dynamin in receptor-mediated endocytosis and mitogenic signal
transduction. J Biol Chem 274:24575–24578.
White KL, Scopton AP, Rives ML, Bikbulatov RV, Polepally PR, Brown PJ,
Kenakin T, Javitch JA, Zjawiony JK, and Roth BL (2014) Identification of
novel functionally selective κ-opioid receptor scaffolds. Mol Pharmacol
85:83–90
Willard FS, Douros J D, Gabe MB, Showalter AD, Wainscott DB,Suter TM.et
al (2020) Tirzepatide is an imbalanced and biased dual GIP and
GLP-1receptor agonist. JCI Insight, 5, e140532.
https://doi.org/10.1172/jci
Wingler LM, Elgeti M, Hilger D, Latorraca NR, Lerch MT, Staus DP, et al
(2019) Angiotensin Analogs with Divergent Bias Stabilize Distinct
Receptor Conformations Cell. 176(3):468-478.e11.
Wingler LM, Skiba MA, McMahon C, Staus DP, Kleinhenz ALW, Suomivuori CM,
et al (2020) Angiotensin and biased analogs induce structurally distinct
active conformations within a GPCR Science. 367(6480):888-892
Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, Shenoy SK,
and Lefkowitz RJ (2007) A unique mechanism of β-blocker action:
carvedilol stimulates β-arrestin signaling. Proc Natl Acad Sci USA
104:16657–16662
Yuliantie E, Darbalaei S, Dai A, Zhao P, Yang D, Sexton PM et al (2020)
Pharmacological characterization of mono-, dual- and tri-peptidic
agonists at GIP and GLP-1 receptors Biochem. Pharmacol.177:114001
Zhao LH, He Q, Yuan Q, Gu Y, He X, Shan H, et al (2023) Conserved class
B GPCR activation by a biased intracellular agonist. Nature. doi:
10.1038/s41586-023-0646
Zidar DA, Violin JD, Whalen EJ, Lefkowitz RJ. (2009). Selective
engagement of G protein receptor kinases (GRKs) encodes distinct
functions of biased ligands. Proc. Natl. Acad. Sci USA 106:9649-9654.
.